ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
2.530
-0.090 (-3.44%)
At close: Sep 17, 2025, 4:00 PM EDT
2.590
+0.060 (2.37%)
Pre-market: Sep 18, 2025, 8:52 AM EDT
ProKidney Market Cap
ProKidney has a market cap or net worth of $744.53 million as of September 18, 2025. Its market cap has increased by 148.18% in one year.
Market Cap
744.53M
Enterprise Value
454.22M
1-Year Change
148.18%
Ranking
Category
Stock Price
$2.53
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $50.55M to $744.53M, an increase of 1,372.87%. That is a compound annual growth rate of 89.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 353.68M | 63.54% |
| Dec 31, 2024 | 216.27M | 80.97% |
| Dec 29, 2023 | 119.50M | -71.69% |
| Dec 30, 2022 | 422.17M | 33.72% |
| Dec 31, 2021 | 315.71M | 524.55% |
| Jun 30, 2021 | 50.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |